Philips Respironics goes mobile with SleepMapper app and web-based solution

 Philips Respironics goes mobile with SleepMapper app and web-based solution

SleepMapper helps sleep apnea patients enhance their therapy experience
through personalized feedback and interactive tools

PR Newswire

MURRYSVILLE, Pa., April 24, 2013

MURRYSVILLE, Pa., April 24, 2013 /PRNewswire/ --Philips Respironics, a unit
of Royal Philips Electronics (NYSE: PHG, AEX: PHIA), today announces the
launch of the SleepMapper self-management system, a robust mobile and
web-based solution for patients diagnosed with obstructive sleep apnea (OSA)
that combines the components of feedback, education and troubleshooting. It is
also the first self-management system for OSA patients that incorporates
motivation enhancement therapy techniques to aid in adherence to sleep
therapy. This innovative application provides sleep apnea patients with the
tools they need to enhance their sleep therapy experience, demonstrating
Philips' commitment to providing patient-focused solutions that help improve
quality of life.

To view the multimedia assets associated with this release, please click
http://www.prnewswire.com/news-releases/philips-respironics-goes-mobile-with-sleepmapper-app-and-web-based-solution-204387451.html

SleepMapper empowers patients who use Philips Respironics System One positive
airway pressure (PAP) devices to stay involved and interested in their therapy
and motivated to stay compliant. A patient can view therapy feedback, set
goals and access information, resources and tutorials about sleep apnea and
the Philips Respironics System One sleep therapy devices and masks.

"Having a tool like SleepMapper in the early stages of my therapy would have
helped," said Sherry Johnston, sleep apnea sufferer and former contestant on
NBC's 'The Biggest Loser'. "I'll now have the information I didn't have access
to before. I can see results every day and the ability to set my goals is
something I enjoy. SleepMapper helps me manage my sleep apnea."

OSA is characterized by a narrowing or closing of the upper airway, which
causes cessation in breathing during sleep. The disorder affects approximately
four percent of men and two percent of women in the United States.^1 Positive
airway pressure (PAP) therapy is considered the gold standard for the
treatment of OSA. Unfortunately, many patients often fail to use PAP therapy.
This poses a serious problem, as OSA that is left untreated or improperly
managed can increase the risk of chronic conditions such as diabetes or heart
disease.^2,3

"Non-adherence to therapy due to poor patient education and not understanding
the disease management process have been inherent obstacles to CPAP success,"
said Mark. S. Aloia, PhD, senior director, global clinical research at Philips
Healthcare. Dr. Aloia has studied CPAP therapy for the past 15 years and
believes "SleepMapper provides patients with a clear path for learning to
manage treatment of their OSA. It allows patients to take ownership and
develop goals to strive toward, which is important because it fosters patient
engagement and instills a level of accountability."

SleepMapper has many benefits for the care provider. John Frank, senior vice
president, general manager, Sleep and Respiratory Care, Philips Home
Healthcare Solutions says, "There are an increasing number of business
challenges for providers. Innovations such as SleepMapper can help providers
continue to offer quality care while making their role more efficient. We are
committed to helping clinicians and homecare providers with solutions that
help their patients adhere to therapy and succeed."

SleepMapper can be downloaded to a smartphone or tablet, or accessed from a
computer. It is available on Google Play, iTunes and www.sleepmapper.com. For
more information about SleepMapper, the patient website is
www.sleepmapper.com. The sleep professional and provider website is
www.philips.us/sleepmapper.

About Royal Philips Electronics:
Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and
well-being company, focused on improving people's lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and Lighting.
Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8
billion and employs approximately 116,000 employees with sales and services in
more than 100 countries. The company is a leader in cardiac care, acute care
and home healthcare, energy efficient lighting solutions and new lighting
applications, as well as male shaving and grooming and oral healthcare. News
from Philips is located at www.philips.com/newscenter.

Related Link
More information on the SleepMapper

^1 World Association of Sleep Medicine (2012). Sleep Apnea. Retrieved March
26, 2013, from http://www.wasmonline.org/.
^2 Gottlieb, Daniel. "Epidemiology and Prevention, Prospective Study of
Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure,
The Sleep Heart Health Study." Circulation. (2010): n. page. Web. 11 Jan.
2013. http://circ.ahajournals.org/content/122/4/352.short.
^3 Aronsohn, Renee, Harry Whitmore, Eve Van Cauter, and Ersa Tasali. "Impact
of Untreated Obstructive Sleep Apnea on Glucose Control in Type 2 Diabetes."
American Journal of Respiratory and Critical Care Medicine. (2009): n. page.
Web. 11 Jan. 2013. http://ajrccm.atsjournals.org/content/181/5/507.short. 

SOURCE Philips Respironics

Website: http://www.sleepmapper.com
Contact: Maryellen Bizzack, Philips Home Healthcare Solutions, +1(724)
387-5006, maryellen.bizzack@philips.com; or Alicia Cafardi, Philips Home
Healthcare Solutions, +1(724) 387-4439, alicia.cafardi@philips.com
 
Press spacebar to pause and continue. Press esc to stop.